← Back to Search

Focused Ultrasound

Transcranial ExAblate for Essential Tremor

N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be followed from the date of treatment until study completion, approximately up to 12 months
Awards & highlights

Study Summary

This trial is testing a new treatment for essential tremor that is safe and effective.

Eligible Conditions
  • Essential Tremor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be followed from the date of treatment until study completion, approximately up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be followed from the date of treatment until study completion, approximately up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The incidence and severity of adverse events (AEs)
Secondary outcome measures
Effectiveness of the ExAblate Transcranial MRgFUS treatment of medication-refractory Essential Tremor (ET) will be determined using the Clinical Rating Scale for Tremor (CRST)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Transcranial ExAblateExperimental Treatment1 Intervention
Transcranial ExAblate
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial ExAblate
2013
N/A
~80

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
88 Previous Clinical Trials
3,654 Total Patients Enrolled
12 Trials studying Essential Tremor
1,018 Patients Enrolled for Essential Tremor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors
2015. "Continued Access Protocol: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Essential Tremors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02289560.
All > Essential Tremor
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top